Edmond de Rothschild Equity Strategies Management III S.à.r.l acquired 61.58% stakes in Oncodesign Precision Medicine Société anonyme (ENXTPA:MLOPM) from Philippe Genne and other managers and minority shareholder on October 19, 2022.

Edmond de Rothschild Equity Strategies Management III S.à.r.l completed the acquisition of 61.58% stakes in Oncodesign Precision Medicine Société anonyme (ENXTPA:MLOPM) from Philippe Genne and other managers and minority shareholder on October 19, 2022.